Studies Evaluate Remdesivir for COVID-19, but Data Still Limited
|
Gilead shares compassionate use data for remdesivir in patients with COVID-19 and a new research paper suggests remdesivir’s mechanism of action could make it effective in combatting the virus.
|
Read more
|